We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$396B
AUM Growth
-$4.47B
Cap. Flow
+$17.3B
Cap. Flow %
4.36%
Top 10 Hldgs %
17.57%
Holding
6,885
New
459
Increased
2,707
Reduced
2,368
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 15.47%
2 Healthcare 9.44%
3 Financials 9.02%
4 Consumer Discretionary 7.88%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMMT icon
5626
Summit Therapeutics
SMMT
$10.8B
$72K ﹤0.01%
60,740
+26,347
+77% +$29.8K
TCRR
5627
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$72K ﹤0.01%
39,914
-43,552
-52% -$126K
ORLA
5628
DELISTED
Orla Mining
ORLA
$71K ﹤0.01%
21,700
-628,136
-97% -$1.93M
EVLO
5629
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$71K ﹤0.01%
1,703
-399
-19% -$18.2K
TERN
5630
DELISTED
Terns Pharmaceuticals
TERN
$70K ﹤0.01%
11,916
-4,672
-28% -$17.4K
ALLT icon
5631
Allot
ALLT
$372M
$69K ﹤0.01%
17,666
+2,802
+19% +$13.3K
ZVO
5632
DELISTED
Zovio Inc. Common Stock
ZVO
$69K ﹤0.01%
481,746
-73,490
-13% -$36.3K
CELU icon
5633
Celularity
CELU
$19.8M
$68K ﹤0.01%
+2,937
New +$89.1K
WATT icon
5634
Energous
WATT
$98.5M
$68K ﹤0.01%
110
-1
-0.9% -$724
OVID icon
5635
Ovid Therapeutics
OVID
$495M
$67K ﹤0.01%
36,074
-7,527
-17% -$15.7K
GRNA
5636
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$67K ﹤0.01%
+29,082
New +$76.1K
CNTA
5637
DELISTED
Centessa Pharmaceuticals
CNTA
$66K ﹤0.01%
16,529
-14
-0.1% -$64
SSU
5638
DELISTED
SIGNA Sports United N.V.
SSU
$66K ﹤0.01%
11,553
+341
+3% +$1.98K
ARQQW icon
5639
Arqit Quantum Warrants
ARQQW
$137K
$65K ﹤0.01%
72,319
+24,999
+53% +$21.7K
SLDB icon
5640
Solid Biosciences
SLDB
$857M
$65K ﹤0.01%
9,337
-16,198
-63% -$163K
SMWB icon
5641
Similarweb
SMWB
$646M
$64K ﹤0.01%
11,004
-2,261
-17% -$18.7K
VTEX icon
5642
VTEX
VTEX
$731M
$64K ﹤0.01%
17,286
+66
+0.4% +$247
OSTRW
5643
DELISTED
Oyster Enterprises Acquisition Corp. Warrant
OSTRW
$64K ﹤0.01%
395,208
BOAS.WS
5644
DELISTED
BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share
BOAS.WS
$64K ﹤0.01%
279,480
OMER icon
5645
Omeros
OMER
$952M
$63K ﹤0.01%
19,893
-92,013
-82% -$427K
SST icon
5646
System1
SST
$13.6M
$63K ﹤0.01%
+1,006
New +$87.7K
BINI
5647
DELISTED
Bollinger Innovations
BINI
0
UTAAW
5648
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$61K ﹤0.01%
275,776
LLAP.WS
5649
DELISTED
Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
LLAP.WS
$60K ﹤0.01%
296,628
STON
5650
DELISTED
StoneMor Inc.
STON
$60K ﹤0.01%
17,520
+5,784
+49% +$19.8K

Similar funds

Goldman Sachs's Q3 2022 Portfolio in Review

As of Q3 2022, Goldman Sachs held 6,885 positions worth $396B, down 1.1% from $400B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Goldman Sachs deployed $17.3B of net new capital in Q3 2022, opening 459 new positions and adding to 2,707 existing holdings. Its largest new stake was Schwab US TIPS ETF: 8,348,958 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $930M trimmed.

  • Goldman Sachs's largest Q3 2022 buy was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
  • Goldman Sachs added most to Visa in Q3 2022, an estimated $2.06B increase.
  • Goldman Sachs's biggest Q3 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $930M.
  • Goldman Sachs fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $236M.
  • Goldman Sachs's ten largest holdings make up 18% of its $396B portfolio in Q3 2022.
  • Goldman Sachs opened 459 new positions and closed 646 in Q3 2022.
  • Goldman Sachs's portfolio value fell 1.1% quarter-over-quarter to $396B.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.